Evidence map›Paper›PMID 34041619›Full record

ArticleLasers in medical science2022

Treatment of partial injury of the calcaneus tendon with heterologous fibrin biopolymer and/or photobiomodulation in rats.

Enéas de Freitas Dutra Júnior, Sílvia Maria Cardoso Magalhães Hidd, Marcello Magri Amaral, Antonio Luiz Martins Maia Filho, Livia Assis, Rui Seabra Ferreira, Benedito Barraviera, Cintia Cristina Santi Martignago, José Figueredo-Silva, Rauirys Alencar de Oliveira and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Heterologous fibrin biopolymer as an emerging approach to peripheral nerve repair: a scoping review.The journal of venomous animals and toxins including tropical diseases · 2024
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Enéas de Freitas Dutra JúniorDepartment of Biomedical Engineering, Instituto Científico E Tecnológico, University Brazil, Carolina FonsecaSão Paulo, 235, Brazil.
Sílvia Maria Cardoso Magalhães HiddDepartment of Biomedical Engineering, Instituto Científico E Tecnológico, University Brazil, Carolina FonsecaSão Paulo, 235, Brazil.
Marcello Magri AmaralDepartment of Biomedical Engineering, Instituto Científico E Tecnológico, University Brazil, Carolina FonsecaSão Paulo, 235, Brazil.
Antonio Luiz Martins Maia FilhoBiotechnology and Biodiversity Research Center, UESPI, Teresina, Piauí, Brazil.
Livia AssisDepartment of Biomedical Engineering, Instituto Científico E Tecnológico, University Brazil, Carolina FonsecaSão Paulo, 235, Brazil.
Rui Seabra FerreiraCenter for the Study of Venoms and Venomous Animals (CEVAP), São Paulo State University (UNESP - Univ Estadual Paulista), Botucatu, São Paulo, Brazil.
Benedito BarravieraCenter for the Study of Venoms and Venomous Animals (CEVAP), São Paulo State University (UNESP - Univ Estadual Paulista), Botucatu, São Paulo, Brazil.
Cintia Cristina Santi MartignagoDepartment of Physiotherapy, Federal University of São Carlos, São Paulo, Brazil.
José Figueredo-SilvaBiotechnology and Biodiversity Research Center, UESPI, Teresina, Piauí, Brazil.
Rauirys Alencar de OliveiraDepartment of Health Sciences, Piauí State University (UESPI), Teresina, PI, Brazil.
Carla Roberta TimDepartment of Biomedical Engineering, Instituto Científico E Tecnológico, University Brazil, Carolina FonsecaSão Paulo, 235, Brazil. carlinha_tim@hotmail.com.ORCID http://orcid.org/0000-0002-4745-9375
Universidade Estadual do Piauí · BRUniversidade Estadual Paulista (Unesp) · BRFundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico · BRUniversidade Federal de São Carlos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to evaluate the new heterologous fibrin biopolymer associated, or not, with photobiomodulation therapy for application in tendon injuries, considered a serious and common orthopedic problem. Thus, 84 Rattus norvegicus had partial transection of the calcaneus tendon (PTCT) and were randomly divided into: control (CG); heterologous fibrin biopolymer (HFB); photobiomodulation (PBM); heterologous fibrin biopolymer + photobiomodulation (HFB + PBM). The animals received HFB immediately after PTCT, while PBM (660 nm, 40 mW, 0.23 J) started 24 h post injury and followed every 24 h for 7, 14, and 21 days. The results of the edema volume showed that after 24 h of PTCT, there was no statistical difference among the groups. After 7, 14, and 21 days, it was observed that the treatment groups were effective in reducing edema when compared to the control. The HFB had the highest edema volume reduction after 21 days of treatment. The treatment groups did not induce tissue necrosis or infections on the histopathological analysis. Tenocyte proliferation, granulation tissue, and collagen formation were observed in the PTCT area in the HFB and HFB + PBM groups, which culminated a better repair process when compared to the CG in the 3 experimental periods. Interestingly, the PBM group revealed, in histological analysis, major tendon injury after 7 days; however, in the periods of 14 and 21 days, the PBM had a better repair process compared to the CG. In the quantification of collagen, there was no statistical difference between the groups in the 3 experimental periods. The findings suggest that the HFB and PBM treatments, isolated or associated, were effective in reducing the volume of the edema, stimulating the repair process. However, the use of HFB alone was more effective in promoting the tendon repair process. Thus, the present study consolidates previous studies of tendon repair with this new HFB. Future clinical trials will be needed to validate this proposal.

Indexed as

Achilles TendonCalcaneusLow-Level Light TherapyAnimalsBiopolymersFibrinRatsRats, WistarBiopolymersFibrinCalcaneus tendonHeterologous fibrin biopolymerPhotobiomodulationRatsTissue repair

Identifiers

PMID34041619
OpenAlexW3165863876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.